David Carbone is an Oncology physician affiliated with University of Hawaii System. OpenAlex indexes 13 publications with 340 citations (h-index 4); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 W 10th Ave Fl 2
Columbus, OH 432101280
Telephone
614-293-5066Provider last certified this registry record 26 Feb 2026.
Clinical trials
- Biomarker Study of Blood Samples From Patients With Non-Small Cell Lung Cancer Treated With Carboplatin and Paclitaxel With or Without Bevacizumab
Sponsor: ECOG-ACRIN Cancer Research Group
- HER-2 Mutations in Tumor Samples From Patients With Advanced Non-Small Cell Lung Cancer Treated on Clinical Trial ECOG-2598
Sponsor: ECOG-ACRIN Cancer Research Group
- Proteomic Profiling in Predicting Response in Patients Receiving Erlotinib for Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Sponsor: Vanderbilt-Ingram Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
39 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AstraZeneca Pharmaceuticals LPProgram year202518 payments$11,472openpaymentsdata.cms.gov ↗
- Bayer Healthcare Pharmaceuticals Inc.Program year202511 payments$10,793openpaymentsdata.cms.gov ↗
- Eli Lilly and CompanyProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
6 NIH research awards on record, funded 2010–2026 per NIH RePORTER. The latest:
- OSU as a Network Lead Academic Participating Site for the NCI NCTN
Ohio State University
FY2025$1,044,921UG1CA233331 - Targeting immunosuppressive adenosine in patients with metastatic non-small cell lung cancer
Ohio State University
FY2025$741,840R01CA248741
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Desiree Medeiros, MD
University of Hawaii System
Dena Towner, MD
University of Hawaii System
Anatte Karmon, MD
University of Hawaii System
Collin Dang, MD
University of Hawaii System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”